← Leaderboards
Andrea Barrio
Sloan-Kettering Inst Can Research
$1,260,462
Attributed
$2,343,923
Total exposure
2
Grants
1
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants.
Funding over time
peak $823K · FY2022–25$1M$750K$500K$250K$0
'22
'23
'24
'25
Funding mix
By agency
NIH$2,343,923 · 2
By mechanism
R01$2,166,923 · 1
R03$177,000 · 1
Top collaborators
- Babak J Mehrara3 shared
Most similar at Sloan-Kettering Inst Can Research
Same institution · by research overlap
- Babak J Mehrara$12,871,847
Others in their field
Other Rising Stars on “Pathologic”
- Gary Mays · Axle Informatics, Llc$59,047,077
- Mari Ostendorf · University Of Washington$51,931,230
- Thomas K Karikari · Wake Forest University Health Sciences$14,340,584
- Hill Georgette · Integrated Laboratory Systems, Llc$10,800,000
- Joon Sup Lee · Emory University$10,751,414
- Jennifer Lee O'Brien · University Of South Florida$10,506,386
Research focus
PathologicLymphedemaOperative Surgical ProceduresSentinel Lymph Node BiopsyAxillary Lymph Node DissectionMalignant Breast NeoplasmSkinNeoadjuvant TherapyProceduresQuality Of LifeWomanProspectivePatient PopulationEligibility DeterminationAdjuvant ChemotherapyLeadBiopsy SpecimenBiopsyAsianBiologyBreast Cancer Risk FactorAnti-Inflammatory AgentsCellsCharacteristics
Grant awards (5)
Mechanisms of racial disparity in breast cancer-related lymphedema$734,550
R01 · FY2025 · CA
Mechanisms of racial disparity in breast cancer-related lymphedema$697,823
R01 · FY2024 · CA
Mechanisms of racial disparity in breast cancer-related lymphedema$734,550
R01 · FY2023 · CA
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer: A Prospective Study$88,500
R03 · FY2023 · CA · contact PI
Sentinel Lymph Node Biopsy after Neoadjuvant Chemotherapy in Patients Presenting with Locally Advanced Breast Cancer: A Prospective Study$88,500
R03 · FY2022 · CA · contact PI